This trial will test whether oxygen, finasteride, and acetazolamide can be effective in reducing unstable breathing and eliminating sleep apnea in the elderly via different mechanisms.
4 Primary · 1 Secondary · Reporting Duration: 2 days to 30 days
Experimental Treatment
100 Total Participants · 3 Treatment Groups
Primary Treatment: Hyperoxia/oxygen · No Placebo Group · Phase 4
Age 60 - 89 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New Jersey | 50.0% |
Michigan | 50.0% |
18 - 65 | 100.0% |
Did not meet criteria | 50.0% |
Met criteria | 50.0% |
John D. Dingell VA Medical Center, Detroit, MI | 100.0% |
100.0% | |